bf/NASDAQ:CADL_icon.jpeg

NASDAQ:CADL

Candel Therapeutics, Inc.

  • Stock

USD

Last Close

14.00

16/05 20:00

Market Cap

34.85M

Beta: -

Volume Today

1.02M

Avg: 28.77K

PE Ratio

−2.46

PFCF: −1.09

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-8.24M
-
-17.68M
114.56%
-36.12M
104.32%
-18.79M
47.97%
-37.94M
101.87%
depreciation and amortization
43K
-
91K
111.63%
232K
154.95%
778K
235.34%
960K
23.39%
deferred income tax
4.61M
-
11.51M
149.97%
stock based compensation
400K
-
2.11M
426.75%
2.96M
40.63%
2.31M
22.14%
3.09M
33.98%
change in working capital
513K
-
1.77M
245.81%
-876K
149.38%
71K
108.11%
45K
36.62%
accounts receivables
inventory
accounts payables
13K
-
289K
2,123.08%
669K
131.49%
-1.21M
281.32%
45K
103.71%
other working capital
500K
-
1.49M
197%
-1.54M
204.04%
1.28M
183.11%
-45K
103.50%
other non cash items
2.11M
-
32K
98.48%
76K
137.50%
-15.78M
20,864.47%
-356K
97.74%
net cash provided by operating activities
-5.18M
-
-9.07M
75.22%
-22.22M
144.93%
-31.42M
41.41%
-34.24M
8.99%
investments in property plant and equipment
-159K
-
-1.48M
828.30%
-1.83M
24.32%
-1.30M
29.32%
-457K
64.76%
acquisitions net
-846K
-
-39.93M
4,619.98%
purchases of investments
-39.11M
-
-6K
99.98%
sales maturities of investments
4.37M
-
39.94M
813.68%
other investing activites
39.93M
-
177K
-
net cash used for investing activites
-35.74M
-
38.45M
207.59%
-1.83M
104.77%
-1.30M
29.32%
-280K
78.41%
debt repayment
-522K
-
-460K
11.88%
-19.91M
-
common stock issued
22.50M
-
30K
99.87%
71.33M
237,683.33%
64K
99.91%
common stock repurchased
dividends paid
other financing activites
21.98M
-
920K
95.81%
465K
49.46%
39.82M
8,463.44%
-121K
100.30%
net cash used provided by financing activities
21.98M
-
490K
97.77%
71.80M
14,553.06%
19.97M
72.18%
-121K
100.61%
effect of forex changes on cash
net change in cash
-18.94M
-
29.87M
257.74%
47.75M
59.83%
-12.74M
126.69%
-34.65M
171.90%
cash at beginning of period
24.38M
-
5.45M
77.67%
35.32M
548.65%
83.07M
135.19%
70.32M
15.34%
cash at end of period
5.45M
-
35.32M
548.65%
83.07M
135.19%
70.32M
15.34%
35.68M
49.26%
operating cash flow
-5.18M
-
-9.07M
75.22%
-22.22M
144.93%
-31.42M
41.41%
-34.24M
8.99%
capital expenditure
-159K
-
-1.48M
828.30%
-1.83M
24.32%
-1.30M
29.32%
-457K
64.76%
free cash flow
-5.34M
-
-10.55M
97.66%
-24.05M
128.06%
-32.72M
36.02%
-34.70M
6.07%

All numbers in USD (except ratios and percentages)